INDAPTA THERAPEUTICS

indapta-therapeutics-logo

Indapta Therapeutics is a privately held biotechnology company developing an NK (natural killer) cell therapy platform for the treatment of blood and solid tumor cancers.

#SimilarOrganizations #People #Financial #Event #Website #More

INDAPTA THERAPEUTICS

Industry:
Biopharma Biotechnology Medical

Founded:
2017-01-01

Address:
San Francisco, California, United States

Country:
United States

Website Url:
http://www.indapta.com

Total Employee:
11+

Status:
Active

Total Funding:
50 M USD


Similar Organizations

accent-therapeutics-logo

Accent Therapeutics

Accent Therapeutics is a biopharmaceutical company.

cygnal-therapeutics-logo

Cygnal Therapeutics

Cygnal Therapeutics is a biotechnology company

enterin-logo

Enterin

Philadelphia-based biotechnology company .

escient-pharmaceuticals-logo

Escient Pharmaceuticals

Escient Pharmaceuticals is a privately held biotechnology company.

excellthera-logo

ExCellThera

ExCellThera is an advanced clinical stage biotechnology company.

eyebiotech-logo

Eyebiotech

Eyebiotech is a privately held ophthalmology biotechnology company.

libra-therapeutics-logo

Libra Therapeutics

Libra Therapeutics is a biotechnology company.

moma-therapeutics-logo

MOMA Therapeutics

MOMA Therapeutics operates as a biotechnology company.

neumora-therapeutics-logo

Neumora Therapeutics

Neumora Therapeutics operates as a clinical-stage biotechnology company.

tessera-therapeutics-logo

Tessera Therapeutics

Tessera Therapeutics is a biotechnology company that focuses on a new category of genetic medicines.


Current Advisors List

lori-hu_image

Lori Hu Board Member @ Indapta Therapeutics
Board_member

laura-stoppel_image

Laura Stoppel Board Member @ Indapta Therapeutics
Board_member

fabio-pucci_image

Fabio Pucci Board Member @ Indapta Therapeutics
Board_member

Current Employees Featured

not_available_image

Mark Frohlich
Mark Frohlich Chief Executive Officer @ Indapta Therapeutics
Chief Executive Officer
2022-01-01

Investors List

leaps-by-bayer_image

Leaps by Bayer

Leaps by Bayer investment in Series A - Indapta Therapeutics

lonza-group_image

Lonza

Lonza investment in Series A - Indapta Therapeutics

myeloma-investment-fund_image

Myeloma Investment Fund

Myeloma Investment Fund investment in Series A - Indapta Therapeutics

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series A - Indapta Therapeutics

vertex-ventures_image

Vertex Ventures

Vertex Ventures investment in Series A - Indapta Therapeutics

Key Employee Changes

Date New article
2022-02-10 Indapta snags $50M financing and signs on former Juno exec as CEO

Official Site Inspections

http://www.indapta.com Semrush global rank: 5.84 M Semrush visits lastest month: 1.42 K

  • Host name: 83.162.211.130.bc.googleusercontent.com
  • IP address: 130.211.162.83
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Indapta Therapeutics" on Search Engine